๐ฌDeep Research
BEAM โ Beam Therapeutics ยท catalysts, narrative & risks
Beam Therapeutics (BEAM) โ Point-in-Time Research as of 2026-11-10
Note: figures below are compiled from the provided sources and are not a recommendation.
Quick facts: Market cap ~$2.73B, 103.5M shares outstanding, ~$26.41 closing price on Nov 6, 2026 [10]; trading around $26โ27 [6][10]. NASDAQ-listed, Healthcare/Biotechnology [background].
Recent catalysts (last ~1โ3 months, AugโNov 2026)
AI-assisted research from the K3vl4r desk โ not personalized investment advice. More research โ